Acquired inhibitor of the intrinsic pathway in a non-haemophilic patient. Control of bleeding by recombinant factor viia.

نویسندگان

  • Ramón Lecumberri
  • Carlos Panzio
  • José Antonio Páramo
  • Marta Pérez Salazar
  • Eduardo Rocha
چکیده

Frickhofen, N. & Rosenfield, S.J. (2000) Immunosuppressive therapy of aplastic anaemia with anti lymphocyte globulin and cyclosporine. Seminars in Haematology, 37, 56–68. Meletis, J., Samarkos, M., Mesogitis, S., Melitis, C., Mougiou, A., Terpos, E., Tsimberidou, A., Andreopoulos, A., Konstantopoulos, K. & Loukopoulos, D. (1998) Severe aplastic anaemia relapsing during a pregnancy; spontaneous remission following a termination. Haematologica, 29, 147–151. Schrezenmeier, H., Marin, P., Raghavachar, A., McCann, S., Hows, Gluckmann, E., Nissen, C., van’t Veer-Korthof, E.T., Ljungman, P. & Hinterberger (1993) Relapse of aplastic anaemia after immunosuppressive treatment, a report from the European Bone Marrow Transplantation Group SAA Working Party. British Journal of Haematology, 85, 371– 377. Viallard, J.-F., Boiron, J.-M., Parrens, M., Moreau, J.-F., Ranchin, V., Reiffers, J., Leng, B. & Pellegrin, J.-L. (2000) Severe pancytopenia triggered by recombinant hepatitis B vaccine. British Journal of Haematology, 110, 230–233. Young, N.S. & Alter, B.P. (eds) (1994) Aplastic Anaemia, Acquired and Inherited. pp. 133–158. W.B. Saunders.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Hemorrhage Treatment Report of Patients Suffering from Glanzmann’s Thrombasthenia Resulting Hospitalization from 2006 to 2011 at Mofid Children’s Hospital

Background: The present study evaluated treatment outcomes and the treatment indexes among Glanzmann’s patients in Mofid Children’s Hospital, Tehran, Iran. Patients and Methods: A retrospective cross-sectional study was performed to evaluate the treatment protocols on 15 Glanzmann’s patients with bleeding therapeutic records in Mofid Children’s Hospital, Tehran, Iran, from 2006 to 2011. Resu...

متن کامل

Individualization of bypassing agent treatment for haemophilic patients with inhibitors utilizing thromboelastography.

The treatment of bleeding for haemophilic patients with inhibitors relies on the use of the bypassing agents, recombinant factor VIIa and factor eight inhibitor bypass activity (FEIBA). While both therapies are effective in the majority of bleeding episodes, there is a significant amount of interindividual variability when it comes to the response to therapy. As of yet, there is no reliable lab...

متن کامل

Use of recombinant factor VIIa to treat life-threatening non-surgical bleeding in a post-partum patient.

Ongoing bleeding from patients who have an acquired coagulopathy post-surgery is a common problem. Strategies that are available to combat this problem revolve around the replacement of coagulation factors, platelets, and red blood cells as necessary. These strategies are not always successful and a more direct approach to activating the coagulation system can be more effective and in some inst...

متن کامل

Illustrated operative management of spontaneous bleeding and compartment syndrome of the lower extremity in a patient with acquired hemophilia A: a case report

INTRODUCTION Spontaneous bleeding resulting in compartment syndrome at the lower adult leg due to acquired hemophilia A is rare. There are no reports on operative management of this entity. CASE PRESENTATION We present a case of atraumatic compartment syndrome of the lower leg due to acquired factor VIII deficiency, in an 83-year-old Caucasian man of European descent. He was treated surgicall...

متن کامل

Evaluation of Aryoseven Safety (Recombinant Activated Factor VII) in Patients with Bleeding Disorders (An Observational Post-Marketing Surveillance Study)

Background: Recombinant activated factor VII induces hemostasis in patients with coagulopathy disorders. AryoSeven™ as a safe Iranian Recombinant activated factor VII has been available on our market. This study was performed to establish the safety of AryoSeven on patients with coagulopathy disorder. Methods: This single-center, descriptive,...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • British journal of haematology

دوره 119 1  شماره 

صفحات  -

تاریخ انتشار 2002